1-4 of 4
Yves Bertrand, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetic and Pharmacodynamic Characterization of Graspa Versus Native L-Asparaginase in Combination with Cooprall Chemotherapy in a Phase 3 Randomized Trial for the Treatment of Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

Xavier Thomas, MD PhD, Yves Bertrand, MDPhD, Andre Baruchel, MD PhD, Nicolas Blin, MD, Emmanuelle Tavernier, MD, Stephane Ducassou, MD, Norbert Vey, Virginie Gandemer, MD PhD, Victoria Cacheux, MD, Francoise Mazingue, MD, Emmanuel Raffoux, Genevieve Plat, MD, Jose Fernandes, MD, Maryline Poiree, MD, Luc Fornecker, MD, Jean-Louis Stephan, MD, Mathilde Hunault, MD PhD, Anne Auvrignon, MD, Thibault Leguay, MD, Stephane Lepretre, MD, Alina Ferster, MD PhD, Isabelle Pellier, MD, Emmanuel Plouvier, MD, Claudine Schmitt, Cecile Bonin, Pharm D, Yann Godfrin, PhD, Iman El Hariry, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2492.
https://doi.org/10.1182/blood.V126.23.2492.2492
Published: 2015
Journal Articles

Expanded Access Program of Graspa for Treatment of Patients with Acute Lymphoblastic Leukemia Unable to Receive Other Form of L-Asparaginase - a Status Update (NCT02197650)

Yves Bertrand, MDPhD, Hervé Dombret, Bruno Quesnel, MD PhD, Jean-Louis Stephan, MD, Claudine Schmitt, MD, Severine Lissandre, MD, Maryline Poiree, MD, Christian Recher, MDPhD, Emmanuel Plouvier, MD, Cécile Dumesnil de Maricourt, MD, David Salako, MSc, Yann Godfrin, PhD, Iman El Hariry, MDPhD
Journal: Blood
Blood (2015) 126 (23): 4877.
https://doi.org/10.1182/blood.V126.23.4877.4877
Published: 2015
Journal Articles

Evaluation of the Impact of the Presence of Neutralizing L-Asparaginase Antibodies on the Efficacy and Safety of Graspa in Phase 3 Randomized Trial Versus Native L-Asparaginase in Patients with Relapsed Acute Lymphoblastic Leukemia (NCT01518517)

Yves Bertrand, MDPhD, Andre Baruchel, MD, Xavier Thomas, MD PhD, Nicolas Blin, MD, Emmanuelle Tavernier, MD, Stephane Ducassou, MD, Norbert Vey, Virginie Gandemer, MD PhD, Victoria Cacheux, MD, Francoise Mazingue, MD, Emmanuel Raffoux, Genevieve Plat, MD, Jose Fernandes, MD, Maryline Poiree, MD, Luc Fornecker, MD, Jean-Louis Stephan, MD, Mathilde Hunault, MD PhD, Anne Auvrignon, MD, Thibault Leguay, MD, Dominique Plantaz, MDPhD, Stephane Lepretre, MD, Alina Ferster, MD PhD, Isabelle Pellier, MD, Emmanuel Plouvier, MD, Claudine Schmitt, Cecile Bonin, Pharm D, Yann Godfrin, PhD, Iman El Hariry, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3734.
https://doi.org/10.1182/blood.V126.23.3734.3734
Published: 2015
Journal Articles

t(12;21)/ ETV6 - RUNX1 Confers a Specific Pattern of In Vivo Sensitivity to Treatments in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL): Results of the Randomized Trials 58881 and 58951 of the EORTC Children Leukemia Group

Caroline Piette, Stefan Suciu, Emmanuelle Clappier, Yves Bertrand, MDPhD, Genevieve Plat, MD, Christophe Chantrain, Vitor Costa, Nicole Dastugue, Alina Ferster, Caroline Gilotay, Sandrine Girard, Nathalie Grardel, Patrick Lutz, Francoise Mazingue, MD, Odile Minckes, Martine Munzer, Emmanuel Plouvier, MD, Nicolas Sirvent, Anne Uyttebroeck, Nadine van Roy, MD, Karima Yakouben, MD, Yves Benoit, Hélène Cavé
Journal: Blood
Blood (2015) 126 (23): 793.
https://doi.org/10.1182/blood.V126.23.793.793
Published: 2015